Catalyst Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK, INC. | 05/02/2025 | 18.80 M | $456.01 M | -3.20% | 15.48% |
VANGUARD GROUP INC | 05/09/2025 | 8.50 M | $206.02 M | 0.76% | 6.99% |
STATE STREET CORP | 05/15/2025 | 5.53 M | $134.11 M | -4.59% | 4.55% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 05/15/2025 | 3.42 M | $82.99 M | 9.23% | 2.82% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 3.14 M | $76.04 M | 11.89% | 2.58% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 2.96 M | $71.69 M | 9.25% | 2.43% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 2.77 M | $67.08 M | 3.75% | 2.28% |
MORGAN STANLEY | 05/15/2025 | 2.39 M | $58.07 M | 14.68% | 1.97% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 2.19 M | $53.05 M | -27.40% | 1.80% |
FUNDSMITH LLP | 05/15/2025 | 2.15 M | $52.17 M | 100.00% | 1.77% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 1.81 M | $43.93 M | 15.47% | 1.49% |
ROYCE & ASSOCIATES LP | 05/06/2025 | 1.60 M | $38.76 M | -14.27% | 1.32% |
NORTHERN TRUST CORP | 05/13/2025 | 1.49 M | $36.04 M | -1.16% | 1.22% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 1.33 M | $32.17 M | 6.40% | 1.09% |
BOSTON PARTNERS | 05/13/2025 | 1.28 M | $30.63 M | -1.28% | 1.05% |
INVESCO LTD. | 05/12/2025 | 1.20 M | $29.09 M | 41.66% | 0.99% |
KENNEDY CAPITAL MANAGEMENT LLC | 05/13/2025 | 1.06 M | $25.74 M | 4.29% | 0.87% |
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 05/14/2025 | 1.04 M | $25.10 M | 48.25% | 0.85% |
PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 977.62 K | $23.71 M | -19.57% | 0.80% |
MACQUARIE GROUP LTD | 05/15/2025 | 934.93 K | $22.66 M | 36.95% | 0.77% |
PACER ADVISORS, INC. | 05/06/2025 | 854.37 K | $20.72 M | -71.09% | 0.70% |
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 05/07/2025 | 786.90 K | $19.08 M | 7.51% | 0.65% |
05/12/2025 | 768.01 K | $17.19 M | 100.00% | 0.63% | |
ABRDN PLC | 05/13/2025 | 765.29 K | $18.56 M | 57.90% | 0.63% |
QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 760.30 K | $18.44 M | 15.33% | 0.63% |
METLIFE INVESTMENT MANAGEMENT, LLC | 05/14/2025 | 724.09 K | $17.56 M | 963.48% | 0.60% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 709.93 K | $17.22 M | -1.88% | 0.58% |
LSV ASSET MANAGEMENT | 05/09/2025 | 703.80 K | $17.07 M | -9.44% | 0.58% |
ALLIANZ ASSET MANAGEMENT GMBH | 05/05/2025 | 694.13 K | $16.83 M | 397.76% | 0.57% |
CITADEL ADVISORS LLC | 05/15/2025 | 685.42 K | $16.62 M | 57.04% | 0.56% |
PRINCIPAL FINANCIAL GROUP INC | 04/28/2025 | 617.51 K | $14.97 M | 2.83% | 0.51% |
LEGAL & GENERAL GROUP PLC | 05/15/2025 | 573.64 K | $13.91 M | 66.45% | 0.47% |
VICTORY CAPITAL MANAGEMENT INC | 05/02/2025 | 539.78 K | $13.09 M | 82.31% | 0.44% |
AMERICAN CENTURY COMPANIES INC | 05/13/2025 | 526.57 K | $12.77 M | 234.52% | 0.43% |
UBS ASSET MANAGEMENT AMERICAS INC | 05/19/2025 | 526.30 K | $12.76 M | 99.43% | 0.43% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2025 | 506.45 K | $12.28 M | -44.53% | 0.42% |
JUPITER ASSET MANAGEMENT LTD | 05/09/2025 | 488.59 K | $11.85 M | 1.37% | 0.40% |
OBERWEIS ASSET MANAGEMENT INC/ | 05/15/2025 | 467.60 K | $11.34 M | 0.11% | 0.38% |
AQR CAPITAL MANAGEMENT LLC | 05/15/2025 | 445.51 K | $10.80 M | -6.60% | 0.37% |
RAYMOND JAMES FINANCIAL INC | 05/13/2025 | 440.52 K | $10.68 M | 33.50% | 0.36% |
GABLES CAPITAL MANAGEMENT INC. | 05/08/2025 | 416.37 K | $10.10 M | -0.28% | 0.34% |
JW ASSET MANAGEMENT, LLC | 05/09/2025 | 413.39 K | $10.02 M | 0.00% | 0.34% |
PUBLIC SECTOR PENSION INVESTMENT BOARD | 05/12/2025 | 410.76 K | $9.96 M | 46.97% | 0.34% |
PRUDENTIAL FINANCIAL INC | 05/13/2025 | 381.18 K | $9.24 M | -31.12% | 0.31% |
JPMORGAN CHASE & CO | 05/12/2025 | 352.53 K | $8.55 M | -52.11% | 0.29% |
NEW VERNON CAPITAL HOLDINGS II LLC | 05/15/2025 | 327.86 K | $13.52 M | 5,531.40% | 0.27% |
FMR LLC | 05/12/2025 | 319.88 K | $7.76 M | 184.38% | 0.26% |
JANUS HENDERSON GROUP PLC | 05/15/2025 | 319.83 K | $7.90 M | -32.81% | 0.26% |
RHUMBLINE ADVISERS | 04/08/2025 | 310.57 K | $7.53 M | -0.56% | 0.26% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 303.53 K | $7.36 M | -41.72% | 0.25% |
Catalyst Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 434 institutional investors and hedge funds held shares of Catalyst Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 18.8 M
VANGUARD GROUP INC: 8.5 M
STATE STREET CORP: 5.53 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 3.42 M
GOLDMAN SACHS GROUP INC: 3.14 M
RENAISSANCE TECHNOLOGIES LLC: 2.96 M
80.20% of Catalyst Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 119.58 M shares in the last 24 months. This purchase volume represents approximately $2.93 B in transactions.